Flinton Capital Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $253K | Buy |
2,624
+320
| +14% | +$30.9K | 0.01% | 615 |
|
|
2019
Q2 | $265K | Buy |
2,304
+144
| +7% | +$16.6K | 0.01% | 634 |
|
|
2019
Q1 | $254K | Sell |
2,160
-848
| -28% | -$99.7K | 0.01% | 630 |
|
|
2018
Q4 | $188K | Sell |
3,008
-2,208
| -42% | -$138K | 0.01% | 659 |
|
|
2018
Q3 | $370K | Buy |
5,216
+160
| +3% | +$11.4K | 0.01% | 571 |
|
|
2018
Q2 | $336K | Buy |
5,056
+544
| +12% | +$36.2K | 0.01% | 534 |
|
|
2018
Q1 | $295K | Buy |
+4,512
| New | +$295K | 0.01% | 562 |
|